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Displaced intra‑articular calcaneal fractures (DIACFs) 
are devastating injuries associated with long and often 
unsatisfactory recovery and life‑altering consequences.[1,2] 
About 40%–85% of patients return to work within 9 months, 
but approximately 20% are not able to return to work within 
a year.[3,4] Within the past 25 years, the trend toward operative 
therapy with the anatomical reconstruction of the calcaneal 
height, length, and the subtalar joint has improved the clinical 
outcome in general, but problems concerning residual pain, 
limited range of motion in the subtalar joint, and posttraumatic 
arthritis remain.
The goal of surgical treatment is to restore the complex foot 
and ankle biomechanics by exact reduction of the subtalar 
posterior facet. This can be accomplished with a standard 
lateral extensile approach and application of a lateral plate.[5] In 
most cases, a good initial reduction can be achieved; however, 
a sizeable bone void beneath the elevated posterior facet will 
be left behind. The residual bone void can predispose the 
calcaneus to collapse despite stable internal fixation. This 
has led some surgeons to fill this bone void with different 
substances, for example, autograft, allograft,[6,7] or synthetic 
bone graft substitutes (BGSs);[8‑10] other surgeons believe that 
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the healing capacity of the well‑vascularized cancellous bone 
of the calcaneus can bridge the void independently and avoid 
calcaneal collapse.[5,11,12] Till date, the opposing positions 
appear to be almost irreconcilable. Interestingly, most groups 
using BGS have shown an improvement in the follow‑up 
radiographs, indicated by a reduced decrease of Böhler’s angle, 
but have failed to show a positive effect on clinical outcome, 
documented by different scoring systems and patient‑reported 
outcome measures.[8‑10]
This could lead to the speculation that initial cartilage 
destruction is more important and might be a better 
predictor of clinical outcome than maintaining the reduction 
postoperatively.
However, until this question has been conclusively answered, 
the patient should be provided with the most optimal treatment 
and the lowest risk profile.
Autografts, especially cancellous bone autografts from the 
iliac crest have a significant risk of morbidity, which should 
limit their use.[13‑16] Allograft carries a small risk of transmitting 
diseases and has limited availability in good quality. Therefore, 
BGS have been introduced to limit these risks.
Calcium phosphate bone substitutes have been used frequently 
in calcaneal fractures.[8,17‑20] A problem with most calcium 
phosphates is that remodeling into bone is prolonged;[17‑19] this 
poses a risk for foreign body reactions, infections, and graft 
failure due to fatigue breakage of the BGS.[17‑19]
The purpose of this study was to evaluate the effect of an 
injectable calcium sulfate/hydroxyapatite BGS that shows 
quick remodeling into host bone, in the treatment of DIACFs. 
This property should further reduce the risk profile of BGS 
and result in a completely biological bone repair.
MEthods
A total of 23 consecutive DIACFs in 18 patients (eight females, 
10 males) with a mean age of 45.7 years (18 to 78 years) who 
underwent surgical treatment were included in this study. Five 
patients had bilateral fractures, of which two were managed 
conservatively, and eight were treated surgically with the 
combination of internal fixation with a locking plate and 
injection of the BGS.
Inclusion criteria
Consecutive patients presenting at our hospital with closed 
DIACFs according to Sanders classification type III and IV[21] 
between September 2010 and November 2014 were included 
in the study. Surgical management consisted of open reduction 
internal fixation with a calcaneal locking compression 
plate (LCP) and bone defect reconstruction using an injectable 
calcium sulfate/hydroxyapatite BGS.
Exclusion criteria
Patients with DIACFs according to the Sanders classification 
type I and type II were not included in this study because these 
types usually do not present with a significant bone defect.[21]
Patients with open fractures were not included since the surgical 
management is different to the treatment of closed fractures.[22] 
Moreover, patients with calcium metabolism disorders or 
a known allergy to components of CERAMENT™|BONE 
VOID FILLER (calcium sulfate, hydroxyapatite, Iohexol, or 
other iodine‑containing substances) were excluded as well for 
safety reasons.
Data collection
Patient demographics, medical history, comorbidities 
and computed tomography (CT) fracture classification 
were collected prospectively. Prolonged wound healing, 
radiographic follow‑up of fracture consolidation, and clinical 
follow‑up were recorded retrospectively as outcome objectives. 
The outcome was assessed by an independent reviewer to 
ensure that all negative outcomes were recorded.
For the radiographic follow‑up and the quality of bone void 
filling by newly‑formed bone X‑rays were assessed by an 
independent examiner that was not involved in the treatment 
of the patients. Initially, each fracture was classified by the 
Sanders classification based on coronal CT slides.[21]
Surgical management
All patients were treated according to the basic principles of 
surgery of calcaneal fractures.
Initial bed rest with cryotherapy, compression, elevation, pain 
management, and medical antiphlogistic therapy was used 
to reduce soft‑tissue swelling and skin problems. Surgery 
was planned after complete consolidation of soft tissue had 
been achieved. For prophylaxis of infection a single shot of 
Cefuroxime 1.5 g was given intravenously.[23] A standard lateral 
L‑shaped incision was used to expose the fracture.[24] After 
open reduction, the fragments were temporally fixed with 
several 1.4 or 1.6 K‑wires and the reduction controlled using 
fluoroscopy. A LCP (Locking calcaneal plate, Depuy‑Synthes, 
Oberdorf, Switzerland) was placed and fixed with locking 
screws [Figures 1 and 2a]. After fixation of the plate, the central 
cancellous bone defect was filled with CERAMENT™|BONE 
Figure 1: A 30‑year‑old male with bilateral calcaneal fractures after a fall 
from height. Preoperative lateral radiograph of right calcaneus
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VOID FILLER [Figure 2b]. The BGS should be injected into 
a dry bony cavity. Therefore, a surgical tourniquet was used, 
if appropriate, until the BGS had hardened. Each defect was 
filled completely and no additional material was added to 
the product. At the end of surgery, direct skin closure was 
achieved in all patients. Standard wound care was applied. 
Patients were mobilized non‑weight‑bearing using crutches 
for 6 weeks, followed by a further 6 weeks of weight bearing 
as tolerated with a walker.
Outcome parameters
The primary outcome parameter was a calcaneal collapse in the 
follow‑up radiographs. Therefore, Böhler’s angle, the crucial 
angle of Gissane, calcaneal facet height, and absolute foot height 
were compared in the immediate postoperative period and the 
1‑year follow up.[25] Secondary outcome parameters included 
the assessment of filling of the central cancellous bone defect 
with bone regenerate, the rate of complications (including 
prolonged wound healing, superficial and deep infection and 
the need for revision surgery) and clinical outcome. Resorption 
of the BGS and filling of the bony defect was accessed by 
comparing the immediate post‑operative radiographs with 
follow‑up radiographs at 1 year. The final clinical outcome 
of the patients was evaluated by the American Orthopaedic 
Foot and Ankle Society (AOFAS) Ankle‑Hindfoot Scale.[26]
rEsults
The mean clinical follow‑up was 22.6 months (12–52 months). 
No patient died during the follow‑up period. According to the 
Sanders classification, there were 11 type III and 10 type IV 
fractures.[21]
Radiographic results
Twenty fractures were available for a radiographic follow‑up 
examination at 1 year.
Böhler’s angle was pre‑operative − 8.9° on an average (range − 47° 
to 22°), post‑operative 23.6° (0°–42°) and at the 1‑year follow‑up 
19.3° (−31°–38°) [Table 1]. There was no decrease in Böhler’s 
angle at 1 year in six fractures. A slight reduction in Böhler’s 
angle of ≤5° at 1 year was found in six and of >5° in eight 
fractures. In the case of a decrease in Böhler’s angle >5°, there 
were two calcaneal collapses of −15°, and −31°, respectively.
The mean crucial angle of Gissane after surgery was 79.6° (21°–
131°) and at the 1‑year follow‑up 87.3° (41°‑138°) [Table 1].
For calcaneal facet height pre‑operative 46.7 mm (34–88 mm), 
postoperative 48.1 mm (34–61 mm) and at the 1‑year follow‑up 
48.9 mm (32–63 mm) were recorded. The absolute foot height 
was preoperative 83.1 mm (57–142 mm), postoperative 
72.2 mm (54‑86 mm) and 71.7 mm at 1 year (57–84 mm).
Resorption of the bone graft substitute and formation of 
new bone
The BGS was clearly visible on the postoperative radiographs 
due to the radiocontrast agent Iohexol [Figure 3]. On the 
radiographs at 1 year, the BGS could not be distinguished from 
the surrounding bone anymore; remnants of the BGS were not 
visible [Figure 4]. New bone formation, however, could not be 
quantified on the follow‑up radiographs because of overlapping 
with the LCP‑plates and screws and the cortical bone. Exact 
quantification would only be possible using CT scans, which 
is not acceptable from an ethical perspective in patients with 
a good clinical outcome (high dose of radiation).
Clinical outcome
Twenty patients were available for the clinical follow‑up 
examination at a minimum of 1 year. The AOFAS score 
was on average 89.8 (range 68–99) and indicated an 
excellent outcome (>90 points) in eleven fractures, a good 
Figure 3: Same case. Postoperative lateral radiograph. CERAMENT™|BONE 
VOID FILLER is clearly visible due to the radiocontrast agent Iohexol
Figure 2: (a) Same case: Intraoperative fluoroscopy: Temporary fixation 
of the fracture with K‑wires and placement of the LCP‑plate. (b) Injection 
of CERAMENT™|BONE VOID FILLER into the bony defect
ba
Table 1: Radiographic measurements before surgery, 
immediately after surgery and at one‑year follow‑up
Radiographic 
parameter
Pre‑operative Post‑operative Follow‑up at 
1 year
Böhler’s Angle ‑8.9° [‑47°‑22°] 23.6° [0°‑42°] 19.3° [‑31‑38°]
Angle of Gissane / 79.6° [21°‑131°] 87.3° [41°‑138°]
Calcaneal facet 
height in mm
46.7 [34‑88] 48.1 [34‑61] 48.9 [32‑63]
Absolute foot 
height in mm
83.1 [57‑142] 72.2 [54‑86] 71.7 [57‑84]
Papadia, et al.: Calcaneal fractures treated by ORIF and a bone graft substitute
Archives of Trauma Research ¦ Volume 7 ¦ Issue 1 ¦ January‑March 2018 5
outcome (75–90 points) in eight and a fair outcome (50–74 
points) in one fracture.[6] Two patients had a calcaneal collapse 
on the follow‑up radiographs at 1 year. Both patients did not 
follow the postoperative non‑weight bearing regime. The first 
patient, a 63‑year‑old female had a Böhler’s angle of −15° at 
36 months, but a clinically satisfying result with 75 points in 
the AOFAS score. The second patient’s Böhler’s angle was −31 
and had an AOFAS score of 92 points.
Wound healing
In 15 fractures, the incisions healed without prolonged wound 
secretion or collection of fluid. Prolonged wound drainage was 
noted in five fractures; four fractures were managed expectantly 
with dressings. In these patients, the secretion stopped without 
further intervention within 15 days (longest drainage).
Disturbed wound healing was noted in one patient. In this 
patient revision surgery with debridement and soft‑tissue 
closure was performed. Further wound healing was without 
complication after revision surgery. No postoperative 
osteomyelitis occurred in any of the patients.
discussion
There is an ongoing debate about whether the use of bone 
grafts or BGS in combination with internal fixation is beneficial 
for the patient in the treatment of DIACFs. Some authors 
consistently use bone grafts,[6,8‑10] some in selected cases,[24,27] 
and others not at all.[5,12,21] The opposing positions appear to be 
almost irreconcilable. To end this discussion, probably a large, 
multicenter randomized controlled trial with strict inclusion 
criteria and a set of outcome measures would be necessary. 
Until this data are available, the patient should receive the most 
optimal treatment and the lowest risk profile.
A resorbable and injectable hydroxyapatite/calcium sulfate 
biocomposite has shown satisfying results in the treatment 
of distal radius fracture malunions[28] and tibial plateau 
fractures.[29] The BGS has the capacity to be transformed into 
host bone, leaving no remnants of the material behind.[30]
Radiographic results
Our radiographic results showed a good reconstruction of 
the posterior facet with an average Böhler’s angle of 23.6°, 
which is comparable to the results of Singh and Vinay for 
type Sanders III and IV fractures using autograft.[7] The 
loss of Böhler’s angle at the 1‑year follow‑up was 4.3° 
on average. Singh and Vinay found a reduction of 3.5° at 
2 years using autograft and 6.2° without bone grafting.[7] 
Schildhauer et al. and Elsner et al. noted no reduction of 
Böhler’s angle using a calcium phosphate cement (Norian 
SRS, Norian Corporation, Cupertino, CA, USA).[8,19] The 
value for a bioresorbable calcium phosphate paste (α‑BMS, 
Etex Corporation, Cambridge, MA, USA) was 6.2° at 1 year[10] 
and for a nanocrystalline hydroxyapatite 3.8° at 1 year.[9] Our 
radiologic results fit well into the range of bioresorbable BGS 
found by other authors.
Clinical outcome
The AOFAS score of the 20 fractures available for follow‑up 
analysis was 89.8, which indicates a good outcome in general. 
Singh et al. found an AOFAS score of 76.4 for patients treated 
with internal fixation and autograft.[7] The comparison of the 
clinical outcome of studies using BGS in DIACFs is difficult 
since many different outcome measures are used (AOFAS, 
SF 36, Creighton‑Nebraska Health Foundation scale, Kerr 
calcaneal score and Zwipp foot score). The AOFAS score, 
the Creighton‑Nebraska Health Foundation scale and the 
Kerr calcaneal score have in common that points are given 
for different objectives, such as the absence of pain, walking 
ability and working ability. The maximum is 100 points; 
usually,>90 points indicates an excellent result. Schildhauer 
et al. reported a Kerr calcaneal score of 80.2 for Norian SRS[8] 
and Huber et al. of 86.0 on the Creighton‑Nebraska Health 
Foundation scale for nanocrystalline hydroxyapatite.[9] As a 
general approximation, our clinical results are comparable with 
the results reported by other surgeons using bone grafts or BGS.
Complications
The revision rate in our cohort was 5.6%, with one patient 
requiring wound revisions due to disturbed wound healing, but 
no implant‑related infection or osteomyelitis developed. The 
rate of delayed wound healing can be as high as 25% in the 
surgical treatment of calcaneal fractures, with a risk of deep 
infection of 1%–4%.[5,31] In smaller cohorts, the rate of infection 
is reported as 11%,[8] 6.9%,[7] 5.3%,[19] 3.8%,[10] and 3.7%,[9] 
respectively. The risk of infection seems to be comparable in 
all the cohorts reported.
conclusions
The use of CERAMENT™|BONE VOID FILLER showed 
good radiological and clinical results, which are comparable 
to autograft and other commercially available BGS in the 
treatment of DIACFs.
The biocomposite was not distinguishable in the follow‑up 
radiographs at 6 months with transformation into host bone. 
The generation of new bone is not only beneficial for long‑term 
stability but might also serve as bone stock in the case of future 
subtalar fusion surgery because of posttraumatic arthritis.
Figure 4: Same case. Follow‑up radiographs anterior‑posterior (a) and 
lateral (b) at 12 months. CERAMENT™|BONE VOID FILLER has been 
completely resorbed
ba
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